Risk stratification in symptomatic intracranial atherosclerotic disease with conventional vascular risk factors and cerebral haemodynamics. Issue 1 (14th September 2022)

• Record Type: Journal Article
• Authors: Tian, Xuan; Fang, Hui; Lan, Linfang; Ip, Hing Lung; Abrigo, Jill; Liu, Haipeng; Zheng, Lina; Fan, Florence S Y; Ma, Sze Ho; Ip, Bonaventure; Song, Bo; Xu, Yuming; Li, Jingwei; Zhang, Bing; Xu, Yun; Soo, Yannie O Y; Mok, Vincent; Wong, Ka Sing; Leung, Thomas W; Leng, Xinyi
• Is Part Of: Stroke and vascular neurology. Volume 8:Issue 1(2023)
• Page Start: 77
• Page End: 85
• Publication Date: 2022-09-14
• Subjects: stroke -- risk factors -- atherosclerosis -- prospective studies; Cerebrovascular disease -- Periodicals; Cardiovascular system -- Diseases -- Periodicals; 616.81005
• DOI: 10.1136/svn-2022-001606
• Languages: English
• ISSNs: 2059-8688

Abstract

Abstract : Background and purpose: Symptomatic intracranial atherosclerotic stenosis (sICAS) is associated with a considerable risk of recurrent stroke despite contemporarily optimal medical treatment. Severity of luminal stenosis in sICAS and its haemodynamic significance quantified with computational fluid dynamics (CFD) models were associated with the risk of stroke recurrence. We aimed to develop and compare stroke risk prediction nomograms in sICAS, based on vascular risk factors and these metrics. Methods: Patients with 50%–99% sICAS confirmed in CT angiography (CTA) were enrolled. Conventional vascular risk factors were collected. Severity of luminal stenosis in sICAS was dichotomised as moderate (50%–69%) and severe (70%–99%). Translesional pressure ratio (PR) and wall shear stress ratio (WSSR) were quantified via CTA-based CFD modelling; the haemodynamic status of sICAS was classified as normal (normal PR&WSSR), intermediate (otherwise) and abnormal (abnormal PR&WSSR). All patients received guideline-recommended medical treatment. We developed and compared performance of nomograms composed of these variables and independent predictors identified in multivariate logistic regression, in predicting the primary outcome, recurrent ischaemic stroke in the same territory (SIT) within 1 year. Results: Among 245 sICAS patients, 20 (8.2%) had SIT. The D2 H2 A nomogram, incorporating diabetes, dyslipidaemia, haemodynamic status of sICAS, hypertension and age ≥50 years, showed good calibration (P for Hosmer-Lemeshow test=0.560) and discrimination (C-statistic 0.73, 95% CI 0.60 to 0.85). It also had better performance in risk reclassification and provided larger net benefits in decision curve analysis, compared with nomograms composed of conventional vascular risk factors only, and plus the severity of luminal stenosis in sICAS. Sensitivity analysis in patients with anterior-circulation sICAS showed similar results. Conclusions: The D2 H2 A nomogram, incorporating conventional vascular risk factors and the haemodynamic significance of sICAS as assessed in CFD models, could be a useful tool to stratify sICAS patients for the risk of recurrent stroke under contemporarily optimal medical treatment.